Download PDF
Thromb Haemost 2009; 102(03): 437-453
DOI: 10.1160/TH09-04-0221
Review Article
Schattauer GmbH

Molecular diversity of anticoagulants from haematophagous animals

Cho Yeow Koh
1   Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore
,
R. Manjunatha Kini
1   Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore
2   Department of Biochemistry, Virginia Commonwealth University Medical Center, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, USA
› Author Affiliations
Further Information

Publication History

Received: 02 April 2009

Accepted after minor revision: 11 June 2009

Publication Date:
22 November 2017 (online)

    Permissions and Reprints

Summary

To obtain blood meals, haematophagous animals are armed with potent pharmacological molecules to overcome several of their hosts’ response systems. Among them, a large number of exogenous anticoagulants which target the haemostatic system have been identified and characterised. Studies on these anticoagulants have expanded our knowledge on the blood coagulation system, and provided a valuable source of antithrombotic therapeutic agents. Advances in genomic, transcriptomic, structural and proteomic tools greatly accelerated the discovery and analysis of the exogenous anticoagulants in recent years. The molecular diversity observed in these molecules is huge and is constantly expanding. In this review, we will provide an overview on the structure, function and mechanism of the exogenous anticoagulants from haematophagous animals and rationalise their molecular diversity.

Keywords

Anticoagulants - haematophagous animals - structure-function relationships - exogenous factors - molecular diversity
 

  • References

  • 1 Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-949.
    CrossrefPubMedGoogle Scholar
  • 2 Furie B, Furie BC. In vivo thrombus formation. J Thromb Haemost 2007; 05 (Suppl. 01) 12-17.
    PubMedGoogle Scholar
  • 3 Davie EW. et al. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-10370.
    CrossrefPubMedGoogle Scholar
  • 4 Koh CY, Kini RM. Anticoagulants from hematophagous animals. Expert Rev Hematol 2008; 01: 135-139.
    CrossrefPubMedGoogle Scholar
  • 5 Ajjan R, Grant PJ. Coagulation and atherothrombotic disease. Atherosclerosis 2006; 186: 240-259.
    CrossrefPubMedGoogle Scholar
  • 6 Gross PL, Weitz JI. New anticoagulants for treatment of venous thromboembolism. Arterioscler Thromb Vasc Biol 2008; 28: 380-386.
    CrossrefPubMedGoogle Scholar
  • 7 Eikelboom JW, Hirsh J. Combined antiplatelet and anticoagulant therapy: clinical benefits and risks. J Thromb Haemost 2007; 05 (Suppl. 01) 255-263.
    CrossrefPubMedGoogle Scholar
  • 8 Wu KK, Matijevic-Aleksic N. Molecular aspects of thrombosis and antithrombotic drugs. Crit Rev Clin Lab Sci 2005; 42: 249-277.
    CrossrefPubMedGoogle Scholar
  • 9 Melnikova I. The anticoagulants market. Nat Rev Drug Discov 2009; 08: 353-354.
    CrossrefPubMedGoogle Scholar
  • 10 Gray E. et al. Heparin and low-molecular-weight heparin. Thromb Haemost 2008; 99: 807-818.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Cranenburg EC. et al. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98: 120-125.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Weitz JI. Emerging anticoagulants for the treatment of venous thromboembolism. Thromb Haemost 2006; 96: 274-284.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Greinacher A, Warkentin TE. The direct thrombin inhibitor hirudin. Thromb Haemost 2008; 99: 819-829.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Warkentin TE. et al. Bivalirudin. Thromb Haemost 2008; 99: 830-839.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Yeh RW, Jang IK. Argatroban: update. Am Heart J 2006; 151: 1131-1138.
    CrossrefPubMedGoogle Scholar
  • 16 Eriksson BI. et al. Dabigatran etexilate. Nat Rev Drug Discov 2008; 07: 557-558.
    CrossrefPubMedGoogle Scholar
  • 17 Abrams PJ, Emerson CR. Rivaroxaban: a novel, oral, direct factor Xa inhibitor. Pharmacotherapy 2009; 29: 167-181.
    CrossrefPubMedGoogle Scholar
  • 18 Ribeiro JM. Blood-feeding arthropods: live syringes or invertebrate pharmacologists?. Infect Agents Dis 1995; 04: 143-152.
    PubMedGoogle Scholar
  • 19 Ribeiro JM, Francischetti IM. Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. Annu Rev Entomol 2003; 48: 73-88.
    CrossrefPubMedGoogle Scholar
  • 20 Salzet M. Anticoagulants and inhibitors of platelet aggregation derived from leeches. FEBS Lett 2001; 492: 187-192.
    CrossrefPubMedGoogle Scholar
  • 21 Champagne DE. Antihemostatic strategies of blood-feeding arthropods. Curr Drug Targets Cardiovasc Haematol Disord 2004; 04: 375-396.
    CrossrefPubMedGoogle Scholar
  • 22 Hovius JW. et al. Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med 2008; 05: e43.
    CrossrefPubMedGoogle Scholar
  • 23 Markwardt F. The development of hirudin as an antithrombotic drug. Thromb Res 1994; 74: 1-23.
    CrossrefPubMedGoogle Scholar
  • 24 Scharf M. et al. Primary structures of new ‘iso-hirudins’. FEBS Lett 1989; 255: 105-110.
    CrossrefPubMedGoogle Scholar
  • 25 Scacheri E. et al. Novel hirudin variants from the leech Hirudinaria manillensis. Amino acid sequence, cDNA cloning and genomic organization. Eur J Biochem 1993; 214: 295-304.
    CrossrefPubMedGoogle Scholar
  • 26 Steiner V. et al. Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis . Biochemistry 1992; 31: 2294-2298.
    CrossrefPubMedGoogle Scholar
  • 27 Stone SR, Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry 1986; 25: 4622-4628.
    CrossrefPubMedGoogle Scholar
  • 28 Myles T. et al. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I. Biochemistry 2001; 40: 4972-4979.
    CrossrefPubMedGoogle Scholar
  • 29 Clore GM. et al. The conformations of hirudin in solution: a study using nuclear magnetic resonance, distance geometry and restrained molecular dynamics. EMBO J 1987; 06: 529-537.
    PubMedGoogle Scholar
  • 30 Haruyama H, Wuthrich K. Conformation of recombinant desulfatohirudin in aqueous solution determined by nuclear magnetic resonance. Biochemistry 1989; 28: 4301-4312.
    CrossrefPubMedGoogle Scholar
  • 31 Vitali J. et al. The structure of a complex of bovine alpha-thrombin and recombinant hirudin at 2.8-A resolution. J Biol Chem 1992; 267: 17670-17678.
    PubMedGoogle Scholar
  • 32 Grutter MG. et al. Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J 1990; 09: 2361-2365.
    PubMedGoogle Scholar
  • 33 Rydel TJ. et al. The structure of a complex of recombinant hirudin and human alpha-thrombin. Science 1990; 249: 277-280.
    CrossrefPubMedGoogle Scholar
  • 34 Rydel TJ. et al. Refined structure of the hirudinthrombin complex. J Mol Biol 1991; 221: 583-601.
    CrossrefPubMedGoogle Scholar
  • 35 Liu CC. et al. Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin. J Am Chem Soc 2007; 129: 10648-10649.
    CrossrefPubMedGoogle Scholar
  • 36 Bode W. et al. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci 1992; 01: 426-471.
    PubMedGoogle Scholar
  • 37 Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 1967; 27: 157-162.
    CrossrefPubMedGoogle Scholar
  • 38 Strube KH. et al. Isolation, sequence analysis, and cloning of haemadin. An anticoagulant peptide from the Indian leech. J Biol Chem 1993; 268: 8590-8595.
    PubMedGoogle Scholar
  • 39 Richardson JL. et al. Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J 2000; 19: 5650-5660.
    CrossrefPubMedGoogle Scholar
  • 40 Richardson JL. et al. Characterization of the residues involved in the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. Biochemistry 2002; 41: 2535-2542.
    CrossrefPubMedGoogle Scholar
  • 41 Huntington JA. Molecular recognition mechanisms of thrombin. J Thromb Haemost 2005; 03: 1861-1872.
    CrossrefPubMedGoogle Scholar
  • 42 Laskowski M, Jr. Kato I. Protein inhibitors of proteinases. Annu Rev Biochem 1980; 49: 593-626.
    CrossrefPubMedGoogle Scholar
  • 43 Bode W, Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem 1992; 204: 433-451.
    CrossrefPubMedGoogle Scholar
  • 44 Mans BJ. et al. Evolution of hematophagy in ticks: common origins for blood coagulation and platelet aggregation inhibitors from soft ticks of the genus Ornithodoros. Mol Biol Evol 2002; 19: 1695-1705.
    CrossrefPubMedGoogle Scholar
  • 45 Lai R. et al. A thrombin inhibitor from the ixodid tick, Amblyomma hebraeum . Gene 2004; 342: 243-249.
    CrossrefPubMedGoogle Scholar
  • 46 Macedo-Ribeiro S. et al. Isolation, cloning and structural characterisation of boophilin, a multifunctional Kunitz-type proteinase inhibitor from the cattle tick. PLoS ONE 2008; 03: e1624.
    CrossrefPubMedGoogle Scholar
  • 47 Liao M. et al. Hemalin, a thrombin inhibitor isolated from a midgut cDNA library from the hard tick Haemaphysalis longicornis . J Insect Physiol 2009; 55: 164-173.
    PubMedGoogle Scholar
  • 48 van de Locht A. et al. The ornithodorin-thrombin crystal structure, a key to the TAP enigma?. EMBO J 1996; 15: 6011-6017.
    PubMedGoogle Scholar
  • 49 Nienaber J. et al. Savignin, a potent thrombin inhibitor isolated from the salivary glands of the tick Ornithodoros savignyi (Acari: Argasidae). Exp Parasitol 1999; 93: 82-91.
    CrossrefPubMedGoogle Scholar
  • 50 Mans BJ. et al. Amino acid sequence and structure modeling of savignin, a thrombin inhibitor from the tick, Ornithodoros savignyi . Insect Biochem Mol Biol 2002; 32: 821-828.
    CrossrefPubMedGoogle Scholar
  • 51 Mans BJ. et al. Characterization of anti-hemostatic factors in the argasid, Argas monolakensis: Implications for the evolution of blood-feeding in the soft tick family. Insect Biochem Mol Biol 2008; 38: 22-41.
    CrossrefPubMedGoogle Scholar
  • 52 Friedrich T. et al. A Kazal-type inhibitor with thrombin specificity from Rhodnius prolixus . J Biol Chem 1993; 268: 16216-16222.
    PubMedGoogle Scholar
  • 53 van de Locht A. et al. Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J 1995; 14: 5149-5157.
    PubMedGoogle Scholar
  • 54 Mende K. et al. Dipetalogastin, a potent thrombin inhibitor from the blood-sucking insect. Dipetalogaster maximus cDNA cloning, expression and characterization. Eur J Biochem 1999; 266: 583-590.
    CrossrefPubMedGoogle Scholar
  • 55 Campos IT. et al. Infestin, a thrombin inhibitor presents in Triatoma infestans midgut, a Chagas’ disease vector: gene cloning, expression and characterization of the inhibitor. Insect Biochem Mol Biol 2002; 32: 991-997.
    CrossrefPubMedGoogle Scholar
  • 56 Lovato DV. et al. The full-length cDNA of anticoagulant protein infestin revealed a novel releasable Kazal domain, a neutrophil elastase inhibitor lacking anticoagulant activity. Biochimie 2006; 88: 673-681.
    CrossrefPubMedGoogle Scholar
  • 57 Campos IT. et al. Identification and characterization of a novel factor XIIa inhibitor in the hematophagous insect, Triatoma infestans (Hemiptera: Reduviidae). FEBS Lett 2004; 577: 512-516.
    CrossrefPubMedGoogle Scholar
  • 58 Flower DR. The lipocalin protein family: structure and function. Biochem J 1996; 318: 1-14.
    CrossrefPubMedGoogle Scholar
  • 59 Noeske-Jungblut C. et al. Triabin, a highly potent exosite inhibitor of thrombin. J Biol Chem 1995; 270: 28629-28634.
    CrossrefPubMedGoogle Scholar
  • 60 Fuentes-Prior P. et al. Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci USA 1997; 94: 11845-11850.
    CrossrefPubMedGoogle Scholar
  • 61 Valenzuela JG. et al. Purification, cloning, and synthesis of a novel salivary anti-thrombin from the mosquito Anopheles albimanus . Biochemistry 1999; 38: 11209-11215.
    CrossrefPubMedGoogle Scholar
  • 62 Francischetti IM. et al. Anophelin: kinetics and mechanism of thrombin inhibition. Biochemistry 1999; 38: 16678-16685.
    CrossrefPubMedGoogle Scholar
  • 63 Zhang D. et al. Thrombostasin: purification, molecular cloning and expression of a novel anti-thrombin protein from horn fly saliva. Insect Biochem Mol Biol 2002; 32: 321-330.
    CrossrefPubMedGoogle Scholar
  • 64 Iwanaga S. et al. Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis . Eur J Biochem 2003; 270: 1926-1934.
    CrossrefPubMedGoogle Scholar
  • 65 Nakajima C. et al. A novel gene encoding a thrombin inhibitory protein in a cDNA library from Haemaphysalis longicornis salivary gland. J Vet Med Sci 2006; 68: 447-452.
    CrossrefPubMedGoogle Scholar
  • 66 Nutt E. et al. The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure. J Biol Chem 1988; 263: 10162-10167.
    PubMedGoogle Scholar
  • 67 Tuszynski GP. et al. Isolation and characterization of antistasin. An inhibitor of metastasis and coagulation. J Biol Chem 1987; 262: 9718-9723.
    PubMedGoogle Scholar
  • 68 Salzet M. et al. Theromin, a novel leech thrombin inhibitor. J Biol Chem 2000; 275: 30774-30780.
    CrossrefPubMedGoogle Scholar
  • 69 Koh CY. et al. Variegin, a novel fast and tight binding thrombin inhibitor from the tropical bont tick. J Biol Chem 2007; 282: 29101-29113.
    CrossrefPubMedGoogle Scholar
  • 70 Waxman L. et al. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 1990; 248: 593-596.
    CrossrefPubMedGoogle Scholar
  • 71 Gaspar AR. et al. Isolation and characterization of an anticoagulant from the salivary glands of the tick, Ornithodoros savignyi (Acari: Argasidae). Exp Appl Acarol 1996; 20: 583-598.
    CrossrefPubMedGoogle Scholar
  • 72 Neeper MP. et al. Characterization of recombinant tick anticoagulant peptide. A highly selective inhibitor of blood coagulation factor Xa. J Biol Chem 1990; 265: 17746-17752.
    PubMedGoogle Scholar
  • 73 Wei A. et al. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa. J Mol Biol 1998; 283: 147-154.
    CrossrefPubMedGoogle Scholar
  • 74 Grutter MG. Proteinase inhibitors: another new fold. Structure 1994; 02: 575-576.
    CrossrefPubMedGoogle Scholar
  • 75 Cappello M. et al. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc Natl Acad Sci USA 1995; 92: 6152-6156.
    CrossrefPubMedGoogle Scholar
  • 76 Mieszczanek J. et al. Anticoagulant peptides from Ancylostoma caninum are immunologically distinct and localize to separate structures within the adult hookworm. Mol Biochem Parasitol 2004; 133: 319-323.
    CrossrefPubMedGoogle Scholar
  • 77 Stassens P. et al. Anticoagulant repertoire of the hookworm Ancylostoma caninum . Proc Natl Acad Sci U S A 1996; 93: 2149-2154.
    CrossrefPubMedGoogle Scholar
  • 78 Harrison LM. et al. Molecular characterization of Ancylostoma inhibitors of coagulation factor Xa. Hookworm anticoagulant activity in vitro predicts parasite bloodfeeding in vivo. J Biol Chem 2002; 277: 6223-6229.
    CrossrefPubMedGoogle Scholar
  • 79 Murakami MT. et al. Intermolecular interactions and characterization of the novel factor Xa exosite involved in macromolecular recognition and inhibition: crystal structure of human Gla-domainless factor Xa complexed with the anticoagulant protein NAPc2 from the hematophagous nematode Ancylostoma caninum . J Mol Biol 2007; 366: 602-610.
    CrossrefPubMedGoogle Scholar
  • 80 Rios-Steiner JL. et al. Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum . J Mol Biol 2007; 371: 774-786.
    CrossrefPubMedGoogle Scholar
  • 81 Mieszczanek J. et al. Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa. Mol Biochem Parasitol 2004; 137: 151-159.
    CrossrefPubMedGoogle Scholar
  • 82 Brankamp RG. et al. Ghilantens: anticoagulantantimetastatic proteins from the South American leech, Haementeria ghilianii . J Lab Clin Med 1990; 115: 89-97.
    PubMedGoogle Scholar
  • 83 Chopin V. et al. Therostasin, a novel clotting factor Xa inhibitor from the rhynchobdellid leech, Theromyzon tessulatum . J Biol Chem 2000; 275: 32701-32707.
    CrossrefPubMedGoogle Scholar
  • 84 Dunwiddie C. et al. Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site. J Biol Chem 1989; 264: 16694-16699.
    PubMedGoogle Scholar
  • 85 Lapatto R. et al. X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa. EMBO J 1997; 16: 5151-5161.
    CrossrefPubMedGoogle Scholar
  • 86 Otlewski J. et al. The many faces of protease-protein inhibitor interaction. EMBO J 2005; 24: 1303-1310.
    CrossrefPubMedGoogle Scholar
  • 87 Stark KR, James AA. A factor Xa-directed anticoagulant from the salivary glands of the yellow fever mosquito Aedes aegypti . Exp Parasitol 1995; 81: 321-331.
    PubMedGoogle Scholar
  • 88 Stark KR, James AA. Isolation and characterization of the gene encoding a novel factor Xa-directed anticoagulant from the yellow fever mosquito, Aedes aegypti . J Biol Chem 1998; 273: 20802-20809.
    CrossrefPubMedGoogle Scholar
  • 89 Joubert AM. et al. Isolation and characterization of an anticoagulant present in the salivary glands of the bont-legged tick, Hyalomma truncatum . Exp Appl Acarol 1995; 19: 79-92.
    CrossrefPubMedGoogle Scholar
  • 90 Ibrahim MA. et al. Factor Xa (FXa) inhibitor from the nymphs of the camel tick Hyalomma dromedarii. Comp Biochem Physiol B Biochem Mol Biol 2001; 130: 501-512.
    CrossrefPubMedGoogle Scholar
  • 91 Crawley JT, Lane DA. The haemostatic role of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2008; 28: 233-242.
    PubMedGoogle Scholar
  • 92 Francischetti IM. et al. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex. Blood 2002; 99: 3602-3612.
    CrossrefPubMedGoogle Scholar
  • 93 Monteiro RQ. et al. Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite. Protein Sci 2008; 17: 146-153.
    PubMedGoogle Scholar
  • 94 Monteiro RQ. et al. Ixolaris: a factor Xa heparinbinding exosite inhibitor. Biochem J 2005; 387: 871-877.
    CrossrefPubMedGoogle Scholar
  • 95 Francischetti IM. et al. Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis . Thromb Haemost 2004; 91: 886-898.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 96 Buddai SK. et al. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase. J Biol Chem 2002; 277: 26689-26698.
    CrossrefPubMedGoogle Scholar
  • 97 Duggan BM. et al. Inherent flexibility in a potent inhibitor of blood coagulation, recombinant nematode anticoagulant protein c2. Eur J Biochem 1999; 265: 539-548.
    CrossrefPubMedGoogle Scholar
  • 98 Rezaie AR. Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J Biol Chem 2000; 275: 3320-3327.
    CrossrefPubMedGoogle Scholar
  • 99 Giugliano RP. et al. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEMTIMI-32 trial. J Am Coll Cardiol 2007; 49: 2398-2407.
    CrossrefPubMedGoogle Scholar
  • 100 Ledizet M. et al. Discovery and pre-clinical development of antithrombotics from hematophagous invertebrates. Curr Med Chem Cardiovasc Hematol Agents 2005; 03: 1-10.
    CrossrefPubMedGoogle Scholar
  • 101 Ribeiro JM. et al. Purification and characterization of prolixin S (nitrophorin 2), the salivary anticoagulant of the blood-sucking bug Rhodnius prolixus. Biochem J 1995; 308 (01) 243-249.
    CrossrefPubMedGoogle Scholar
  • 102 Isawa H. et al. The insect salivary protein, prolixin-S, inhibits factor IXa generation and Xase complex formation in the blood coagulation pathway. J Biol Chem 2000; 275: 6636-6641.
    CrossrefPubMedGoogle Scholar
  • 103 Zhang Y. et al. Nitrophorin-2: a novel mixed-type reversible specific inhibitor of the intrinsic factor-X activating complex. Biochemistry 1998; 37: 10681-10690.
    CrossrefPubMedGoogle Scholar
  • 104 Andersen JF, Montfort WR. The crystal structure of nitrophorin 2. A trifunctional antihemostatic protein from the saliva of Rhodnius prolixus. J Biol Chem 2000; 275: 30496-30503.
    CrossrefPubMedGoogle Scholar
  • 105 Kato N. et al. Identification and characterization of the plasma kallikrein-kinin system inhibitor, haemaphysalin, from hard tick, Haemaphysalis longicornis. Thromb Haemost 2005; 93: 359-367.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 106 Isawa H. et al. A mosquito salivary protein inhibits activation of the plasma contact system by binding to factor XII and high molecular weight kininogen. J Biol Chem 2002; 277: 27651-27658.
    CrossrefPubMedGoogle Scholar
  • 107 Tanaka AS. et al. A double headed serine proteinase inhibitor--human plasma kallikrein and elastase inhibitor--from Boophilus microplus larvae. Immunopharmacology 1999; 45: 171-177.
    CrossrefPubMedGoogle Scholar
  • 108 Sasaki SD. et al. Boophilus microplus tick larvae, a rich source of Kunitz type serine proteinase inhibitors. Biochimie 2004; 86: 643-649.
    CrossrefPubMedGoogle Scholar
  • 109 Sant’Anna AS. et al. Rhipicephalus sanguineus trypsin inhibitors present in the tick larvae: isolation, characterization, and partial primary structure determination. Arch Biochem Biophys 2003; 417: 176-182.
    CrossrefPubMedGoogle Scholar
  • 110 Yang L. et al. Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases. Blood 2004; 104: 1753-1759.
    CrossrefPubMedGoogle Scholar
  • 111 Ciprandi A. et al. Boophilus microplus: its saliva contains microphilin, a small thrombin inhibitor. Exp Parasitol 2006; 114: 40-46.
    CrossrefPubMedGoogle Scholar
  • 112 Horn F. et al. Boophilus microplus anticoagulant protein: an antithrombin inhibitor isolated from the cattle tick saliva. Arch Biochem Biophys 2000; 384: 68-73.
    CrossrefPubMedGoogle Scholar
  • 113 Ricci CG. et al. A thrombin inhibitor from the gut of Boophilus microplus ticks. Exp Appl Acarol 2007; 42: 291-300.
    CrossrefPubMedGoogle Scholar
  • 114 Electricwala A. et al. Isolation of thrombin inhibitor from the leech Hirudinaria manillensis. Blood Coagul Fibrinolysis 1991; 02: 83-89.
    CrossrefPubMedGoogle Scholar
  • 115 Bock PE. et al. Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost 2007; 05 (Suppl. 01) 81-94.
    CrossrefPubMedGoogle Scholar
  • 116 Maraganore JM. et al. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 1990; 29: 7095-7101.
    CrossrefPubMedGoogle Scholar
  • 117 Hong SJ, Kang KW. Purification of granulin-like polypeptide from the blood-sucking leech, Hirudo nipponia. Protein Expr Purif 1999; 16: 340-346.
    CrossrefPubMedGoogle Scholar
  • 118 Cappello M. et al. Tsetse thrombin inhibitor: bloodmeal-induced expression of an anticoagulant in salivary glands and gut tissue of Glossina morsitans morsitans. Proc Natl Acad Sci U S A 1998; 95: 14290-14295.
    CrossrefPubMedGoogle Scholar
  • 119 Ibrahim MA. et al. Isolation and properties of two forms of thrombin inhibitor from the nymphs of the camel tick Hyalomma dromedarii (Acari: Ixodidae). Exp Appl Acarol 2001; 25: 675-698.
    CrossrefPubMedGoogle Scholar
  • 120 Zhu K. et al. Isolation and characterization of americanin, a specific inhibitor of thrombin, from the salivary glands of the lone star tick Amblyomma americanum (L.). Exp Parasitol 1997; 87: 30-38.
    CrossrefPubMedGoogle Scholar
  • 121 Motoyashiki T. et al. Isolation of anticoagulant from the venom of tick, Boophilus calcaratus, from Uzbekistan. Thromb Res 2003; 110: 235-241.
    CrossrefPubMedGoogle Scholar
  • 122 Waidhet-Kouadio P. et al. Purification and characterization of a thrombin inhibitor from the salivary glands of a malarial vector mosquito, Anopheles stephensi. Biochim Biophys Acta 1998; 1381: 227-233.
    CrossrefPubMedGoogle Scholar
  • 123 Arocha-Pinango CL. et al. Inventory of exogenous hemostatic factors derived form arthropods. Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Subcommittee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1999; 81: 647-656.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 124 Abebe M. et al. Simulidin: a black fly (Simulium vittatum) salivary gland protein with anti-thrombin activity. J Insect Physiol 2008; 41: 1001-1006.
    PubMedGoogle Scholar
  • 125 Kazimirova M. et al. Anticoagulant activities in salivary glands of tabanid flies. Med Vet Entomol 2002; 16: 301-309.
    CrossrefPubMedGoogle Scholar
  • 126 Stark KR, James AA. Salivary gland anticoagulants in culicine and anopheline mosquitoes (Diptera:Culicidae). J Med Entomol 1996; 33: 645-650.
    CrossrefPubMedGoogle Scholar
  • 127 Abebe M. et al. Anticoagulant activity in salivary gland extracts of black flies (Diptera: Simuliidae). J Med Entomol 1994; 31: 908-11.
    CrossrefPubMedGoogle Scholar
  • 128 Pereira MH. et al. Anticoagulant activity of Triatoma infestans and Panstrongylus megistus saliva (Hemiptera/Triatominae). Acta Trop 1996; 61: 255-261.
    CrossrefPubMedGoogle Scholar
  • 129 Narasimhan S. et al. A novel family of anticoagulants from the saliva of Ixodes scapularis. Insect Mol Biol 2002; 11: 641-650.
    CrossrefPubMedGoogle Scholar
  • 130 Faria F. et al. A new factor Xa inhibitor (lefaxin) from the Haementeria depressa leech. Thromb Haemost 1999; 82: 1469-1473.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 131 Fernandez AZ. et al. Draculin, the anticoagulant factor in vampire bat saliva, is a tight-binding, noncompetitive inhibitor of activated factor X. Biochim Biophys Acta 1999; 1434: 135-142.
    CrossrefPubMedGoogle Scholar
  • 132 Zhu K. et al. Identification and characterization of anticoagulant activities in the saliva of the lone star tick, Amblyomma americanum (L.). J Parasitol 1997; 83: 38-43.
    CrossrefPubMedGoogle Scholar
  • 133 Perez de Leon AA. et al. Anticoagulant activity in salivary glands of the insect vector Culicoides variipennis sonorensis by an inhibitor of factor Xa. Exp Parasitol 1998; 88: 121-130.
    CrossrefPubMedGoogle Scholar
  • 134 Jacobs JW. et al. Isolation and characterization of a coagulation factor Xa inhibitor from black fly salivary glands. Thromb Haemost 1990; 64: 235-238.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 135 Condra C. et al. Isolation and structural characterization of a potent inhibitor of coagulation factor Xa from the leech Haementeria ghilianii. Thromb Haemost 1989; 61: 437-441.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 136 Abebe M. et al. Novel anticoagulant from salivary glands of Simulium vittatum (Diptera: Simuliidae) inhibits activity of coagulation factor V. J Med Entomol 1996; 33: 173-176.
    CrossrefPubMedGoogle Scholar
  • 137 Gordon JR, Allen JR. Factors V and VII anticoagulant activities in the salivary glands of feeding Dermacentor andersoni ticks. J Parasitol 1991; 77: 167-170.
    CrossrefPubMedGoogle Scholar
  • 138 Limo MK. et al. Purification and characterization of an anticoagulant from the salivary glands of the ixodid tick Rhipicephalus appendiculatus. Exp Parasitol 1991; 72: 418-429.
    CrossrefPubMedGoogle Scholar
  • 139 Kim DR, Kang KW. Amino acid sequence of piguamerin, an antistasin-type protease inhibitor from the blood sucking leech Hirudo nipponia. Eur J Biochem 1998; 254: 692-697.
    CrossrefPubMedGoogle Scholar